AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
NRXS Neuraxis
- 2.310
- +0.040+1.76%
Close Mar 21 16:00 ET
16.67MMarket Cap-1.89P/E (TTM)
2.333High2.150Low25.53KVolume2.333Open2.270Pre Close56.87KTurnover0.76%Turnover RatioLossP/E (Static)7.22MShares3.78052wk High8.05P/B7.76MFloat Cap1.99052wk Low--Dividend TTM3.36MShs Float6.930Historical High--Div YieldTTM8.07%Amplitude1.800Historical Low2.227Avg Price1Lot Size
Neuraxis Stock Forum
Sign in to post a comment
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...
29
14
2
$Neuraxis (NRXS.US)$
NeurAxis Delivers Record Q4: 43% Revenue Growth Plus Major FDA and Insurance Wins
NeurAxis Delivers Record Q4: 43% Revenue Growth Plus Major FDA and Insurance Wins
$Neuraxis (NRXS.US)$ Fourth Quarter and Fiscal Year 2024 Financial Results
Revenues in the fourth quarter of 2024 were $761 thousand, up 43% compared to $531 thousand in the fourth quarter of 2023. Unit sales increased approximately 45% due to growth from patients with full insurance reimbursement and the Company's financial assistance program that offers discounts for patients without insurance coverage. The Company continues to see great improvements in recent months, gaining posi...
Revenues in the fourth quarter of 2024 were $761 thousand, up 43% compared to $531 thousand in the fourth quarter of 2023. Unit sales increased approximately 45% due to growth from patients with full insurance reimbursement and the Company's financial assistance program that offers discounts for patients without insurance coverage. The Company continues to see great improvements in recent months, gaining posi...
$Neuraxis (NRXS.US)$
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
Tuesday, 21st January at 1:45 pm
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for Percutaneous Elec...
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
Tuesday, 21st January at 1:45 pm
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for Percutaneous Elec...
1
$Neuraxis (NRXS.US)$
01/21/2025 - 06:00 AM
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS), with Molina Healthcare. Molina, with over 40 years in operation, has approximately 5.1 million...
01/21/2025 - 06:00 AM
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS), with Molina Healthcare. Molina, with over 40 years in operation, has approximately 5.1 million...
1
$Neuraxis (NRXS.US)$ NeurAxis Announces Molina Healthcare Coverage For PENFS Therapy IB-Stim, FDA-Cleared For Treating Abdominal Pain In IBS Adolescents
Benzinga· 4 mins ago
Benzinga· 4 mins ago
1
1
$Neuraxis (NRXS.US)$
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
Tuesday, 10th December at 9:00 am
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software.
NeurAxis Inc. will begin the process of commercially marketing RED and expects initial revenues in 1Q25 as there is a Category I CPT code assigned to t...
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
Tuesday, 10th December at 9:00 am
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software.
NeurAxis Inc. will begin the process of commercially marketing RED and expects initial revenues in 1Q25 as there is a Category I CPT code assigned to t...
$Neuraxis (NRXS.US)$ NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market
3 MINUTES AGO, 9:00 AM EST
VIA GLOBENEWSWIRE
3 MINUTES AGO, 9:00 AM EST
VIA GLOBENEWSWIRE
1
$Lion Group (LGHL.US)$ $Neuraxis (NRXS.US)$ $Pacific Mercantile Bancorp (PNBK.US)$ $Powell Max (PMAX.US)$ $Inspire Veterinary Partners (IVP.US)$ $Lobo EV Technologies (LOBO.US)$ $DatChat (DATS.US)$ $Erayak Power Solution Group (RAYA.US)$ $Silexion Therapeutics (SLXN.US)$ $Venus Concept (VERO.US)$ $Highway Holdings (HIHO.US)$ $Genprex (GNPX.US)$ $Digital Brands Group (DBGI.US)$
📊⚡️📊
📊⚡️📊
4
2
$Neuraxis (NRXS.US)$ Neuraxis Announces New Submission to the FDA for the Expansion of Its Ib-Stim Label; Provides Compliance With NYSE Guidelines on Audit Disclosure
No comment yet
Mangkawat : dr jag. delution of pnbk.us mean possible to decline?
Jaguar8 OP Mangkawat : The news itself is dilution for existing shareholders BUT take note not all PP plummets. It all comes down to market sentiment. Look at it- it is up.
HannChau : bro just rest you don't owe anyone anything here.
Riyan5426 : take care
别关注我 你们很烦 : $Phoenix Motor (PEV.US)$ Should this Stocks be exited?
View more comments...